| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 0.01 | 96.7% | 95.7% |
| Total Income | 0.01 | 96.7% | 95.7% |
| Expenditure | 3.72 | 3.0% | 47.6% |
| PBT | — | ||
| Net Profit | -3.04 | 14.3% | 178.9% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.33 | 10.0% | 153.8% |
BioRestorative Therapies Reports Q3 2025 Results
04 May 2026 · 4 May, 7:27 am
Summary
BioRestorative Therapies, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2025. The press release also provided a business update and included details regarding the conference call to be held to discuss the third quarter results. The information contained in the press release is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission.
Key Highlights
- 1
BioRestorative Therapies, Inc. announced its financial results for the third quarter ended September 30, 2025.
- 2
The press release included details regarding the conference call to discuss the third quarter results.
- 3
A copy of the press release is furnished as Exhibit 99.1.
- 4
The information contained in the press release is summary information.
Informational and educational content only. Not investment advice.